We assign a fundamental rating of 2 out of 10 to PHIO. PHIO was compared to 525 industry peers in the Biotechnology industry. The financial health of PHIO is average, but there are quite some concerns on its profitability. PHIO has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year PHIO has reported negative net income.
PHIO had a negative operating cash flow in the past year.
In the past 5 years PHIO always reported negative net income.
PHIO had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

PHIO has a Return On Assets of -69.13%. This is in the lower half of the industry: PHIO underperforms 62.10% of its industry peers.
PHIO's Return On Equity of -80.83% is in line compared to the rest of the industry. PHIO outperforms 51.43% of its industry peers.

		Industry Rank	Sector Rank
ROA	-69.13%
ROE	-80.83%
ROIC	N/A

ROA(3y)-110.57%

ROA(5y)-88.07%

ROE(3y)-133.2%

ROE(5y)-105.54%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PHIO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, PHIO has more shares outstanding
Compared to 5 years ago, PHIO has more shares outstanding
There is no outstanding debt for PHIO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

PHIO has an Altman-Z score of -15.77. This is a bad value and indicates that PHIO is not financially healthy and even has some risk of bankruptcy.
PHIO has a Altman-Z score of -15.77. This is amonst the worse of the industry: PHIO underperforms 80.00% of its industry peers.
There is no outstanding debt for PHIO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-15.77

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

PHIO has a Current Ratio of 6.90. This indicates that PHIO is financially healthy and has no problem in meeting its short term obligations.
PHIO has a better Current ratio (6.90) than 69.52% of its industry peers.
PHIO has a Quick Ratio of 6.90. This indicates that PHIO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 6.90, PHIO is in the better half of the industry, outperforming 69.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	6.9
Quick Ratio	6.9

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PHIO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.87%, which is quite impressive.

EPS 1Y (TTM)81.87%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%71.43%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, PHIO will show a very strong growth in Earnings Per Share. The EPS will grow by 23.91% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y75.37%

EPS Next 2Y35.74%

EPS Next 3Y23.91%

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

PHIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PHIO. No positive earnings are expected for the next year.